Article thumbnail

Perinatal Exogenous Nitric Oxide in Fawn-Hooded Hypertensive Rats Reduces Renal Ribosomal Biogenesis in Early Life

By Sebastiaan Wesseling, Paul B. Essers, Maarten P. Koeners, Tamara C. Pereboom, Branko Braam, Ernst E. van Faassen, Alyson W. MacInnes and Jaap A. Joles

Abstract

Nitric oxide (NO) is known to depress ribosome biogenesis in vitro. In this study we analyzed the influence of exogenous NO on ribosome biogenesis in vivo using a proven antihypertensive model of perinatal NO administration in genetically hypertensive rats. Fawn-hooded hypertensive rat (FHH) dams were supplied with the NO-donor molsidomine in drinking water from 2 weeks before to 4 weeks after birth, and the kidneys were subsequently collected from 2 day, 2 week, and 9 to 10-month-old adult offspring. Although the NO-donor increased maternal NO metabolite excretion, the NO status of juvenile renal (and liver) tissue was unchanged as assayed by EPR spectroscopy of NO trapped with iron-dithiocarbamate complexes. Nevertheless, microarray analysis revealed marked differential up-regulation of renal ribosomal protein genes at 2 days and down-regulation at 2 weeks and in adult males. Such differential regulation of renal ribosomal protein genes was not observed in females. These changes were confirmed in males at 2 weeks by expression analysis of renal ribosomal protein L36a and by polysome profiling, which also revealed a down-regulation of ribosomes in females at that age. However, renal polysome profiles returned to normal in adults after early exposure to molsidomine. No direct effects of molsidomine were observed on cellular proliferation in kidneys at any age, and the changes induced by molsidomine in renal polysome profiles at 2 weeks were absent in the livers of the same rats. Our results suggest that the previously found prolonged antihypertensive effects of perinatal NO administration may be due to epigenetically programmed alterations in renal ribosome biogenesis during a critical fetal period of renal development, and provide a salient example of a drug-induced reduction of ribosome biogenesis that is accompanied by a beneficial long-term health effect in both males and females

Topics: Genetics
Publisher: Frontiers Research Foundation
OAI identifier: oai:pubmedcentral.nih.gov:3268605
Provided by: PubMed Central

Suggested articles

Citations

  1. (2011). 3389/fgene.2011.00052 This article was submitted to Frontiers in Epigenomics, a specialty of Frontiers in Genetics. Copyright ©
  2. Aadac Arylacetamide deacetylase (esterase)
  3. (2007). Ablation of ribosomal protein L22 selectivelyimpairsalphabetaTcelldevelopment by activation of a p53-dependent checkpoint. Immunity
  4. Actg2 Actin, gamma 2, smooth muscle,
  5. Aldh1a2 Aldehyde dehydrogenase family 1, subfamily
  6. Amfr Autocrine motility factor receptor
  7. Anpep Alanyl (membrane) aminopeptidase
  8. Cidea Cell death-inducing DNA fragmentation factor, alpha subunit-like effector A
  9. Cox8h Cytochrome c oxidase subunit VIII-H (heart/muscle)
  10. Cyp1a1 Cytochrome P450, family 1, subfamily a,
  11. Ddit4l DNA-damage-inducible transcript 4-like −0.389
  12. (2005). Distinct roles for the kidney and systemic tissues in blood pressure regulation by the reninangiotensin system.
  13. Ednrb Endothelin receptor type
  14. (2011). Eif2s3x Eukaryotic translation initiation factor 2, subunit 3, structural gene X-linked −0.021 0.228 0.096 (Continued) Frontiers
  15. Eraf Erythroid associated factor
  16. Fabp4 Fatty acid binding protein 4, adipocyte
  17. Fam151a Family with sequence similarity 151, member A
  18. Fem1b Feminization 1 homolog b (C.
  19. galactose binding,
  20. (1998). Genetic differences define severity of renal damage after L-NAME-induced hypertension in rats.
  21. Hbb Hemoglobin beta chain complex
  22. (1998). Inhibition of protein synthesis by nitricoxidecorrelateswithcytostatic activity: nitric oxide induces phosphorylationofinitiationfactoreIF-2 alpha.
  23. LOC497772 Hypothetical gene supported by
  24. LOC500438 ORF2 consensus sequence encoding endonuclease and reverse transcriptase minus RNaseH
  25. LOC501405 GTPase activating protein testicular
  26. LOC501562 ORF2 consensus sequence encoding endonuclease and reverse transcriptase minus RNaseH
  27. Lrpap1 Low density lipoprotein receptor-related protein associated protein 1
  28. Ms4a4a Membrane-spanning 4-domains, subfamily A,
  29. (2011). Mutation in ribosomal protein L21 underlies hereditary hypotrichosis simplex.
  30. (2000). Nitric oxide inhibits growth of glomerular mesangialcells:roleofthetranscription factor EGR-1.
  31. (2000). Nitric oxide-dependent ribosomal RNA cleavage is associated with inhibition of ribosomal peptidyltransferaseactivityinANA-
  32. Nradd Neurotrophin receptor associated death domain
  33. Nrep Neuronal regeneration-related protein
  34. Obfc2a Oligonucleotide/oligosaccharide-binding fold containing
  35. Peci Peroxisomal delta3, delta2-enoyl-coenzyme A isomerase
  36. (2011). Perinatal exogenous nitric oxide in fawn-hooded hypertensive rats reduces renal ribosomal biogenesis in early life.
  37. (2004). Persistentloweringof pressurebytransplanting kidneys from adult spontaneously hypertensive rats treated with brief antihypertensive therapy.
  38. prostate androgen induced
  39. Ptprcap Protein tyrosine phosphatase, receptor type,
  40. Ralb v-ral simian leukemia viral oncogene homolog
  41. (2003). Rapamycin has a deleterious effect on MIN-6 cells and rat and human islets.
  42. (2008). Renal medullary oxidative stress, pressure-natriuresis, and hypertension.
  43. RGD1560523 S-adenosylmethionine synthetase gamma form (methionine adenosyltransferase)
  44. RGD1561090 Protein tyrosine phosphatase, receptor type,
  45. Rhd Rh blood group,
  46. Rhoa ras homolog gene family,
  47. (1999). Sanij,E.,andHannan,R.D.(2009).The role of UBF in regulating the structure and dynamics of transcriptionally active rDNA chromatin.
  48. Scnn1a Sodium channel, non-voltage-gated, type I,
  49. Sgk Serum/glucocorticoid regulated kinase
  50. Shc1 src homology 2 domain-containing transforming protein
  51. Slc25a25 Solute carrier family 25 (mitochondrial carrier, phosphate carrier)
  52. Slc34a3 Solute carrier family 34 (sodium phosphate),
  53. Slc7a13 Solute carrier family 7 (cationic amino acid transporter,
  54. Stat6 Signal transducer and activator of transcription 6 (predicted), transcript variant 1
  55. (2011). submaxillary gland S3 −0.113 −0.039 −0.771 (Continued) www.frontiersin.org
  56. (2009). Synthesis andfunctionofribosomalproteins– fadingmodelsandnewperspectives.
  57. (2004). The mTOR signaling pathway mediates control of ribosomal protein mRNA translation
  58. (2010). The nitric oxide donor molsidomine rescues cardiac function in rats with chronic kidney disease and cardiac dysfunction.
  59. (1998). The use of nitric oxide donors in pharmacological studies.NaunynSchmiedebergsArch.
  60. Thrsp Thyroid hormone responsive protein
  61. Tnfrsf21 Tumor necrosis factor receptor superfamily,
  62. Trpv1 Transient receptor potential cation channel, subfamily V,
  63. Tyrobp Tyro protein tyrosine kinase binding protein
  64. Ucp1 Uncoupling protein 1 (mitochondrial, proton carrier)

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.